HCA – Dividend Returns, History & Calculator

Dividend Challenger 5 Years

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care,

...

Company Info

Symbol HCA

Company HCA Healthcare, Inc.

Sector Healthcare

Industry Medical Care Facilities

Website Visit

Market Cap $98,335.8M

Price Data

Price $420.25

Price Change +1.85

Price Change % +0.44%

Next Earnings Oct 24, 2025

Low (52W) $289.98

High (52W) $439.01

Dividend Data

Div Yield 68.53%

5Y Avg Yield 83.73%

Current Div $0.720

Payouts/Year 4

Annualized $2.880

Previous Div $0.720

Ex-Date Sep 16, 2025

Growth Rates

Chowder Number 28.4

DGR 1Y 9.3%

DGR 3Y 9.3%

DGR 5Y 27.7%

Total Returns

TTR 1Y - With Specials 4.2%

TTR 3Y - With Specials 29.1%

TTR 1Y - No Specials 4.2%

TTR 3Y - No Specials 29.1%

Fair Value

Fair Value (P/E 10) $191.00

FV (P/E 10) % 120.0%

Fair Value (Peter Lynch) $119.15

FV (Peter Lynch) % 253.0%

Fair Value (Blended) $209.38

FV (Blended) % 101.0%

Financial Metrics

Revenue 1Y 8.7%

NPM 8.2%

CF/Share $51.01

Current R 1.0x

Debt/Capital 1.1%

ROTC 15.7%

P/E 17.6x

PEG 2.24

📊 Financial data last updated: October 16, 2025 11:07 am

Calculate your HCA Dividend Returns

Quickly and easily calculate HCA dividend yield using our HCA calculator. Adjust the fields below to see how your HCA investments snowball over time.

Initial Investment: The lump sum you’re investing on day 1. Share Price: The current market price of one share. Dividend Amount (per payout): Enter the dividend paid per share each payout (e.g., quarterly for many ETFs). Annual yield is computed from this and the selected frequency. Dividend Frequency: How often you receive dividends (e.g. quarterly). Dividend Growth Rate: The yearly increase in dividend payouts (as a percentage). Share Price Growth: Expected annual increase in share price over time. Extra Investment: The amount you invest regularly (e.g. each month). Extra Invest Frequency: How often your extra investment is made (e.g. monthly). Length of Investment: How long you plan to keep investing and compounding.

Show Idealized Scenario (Assumes all future extra investments and dividends are made on Day 1 and reinvested instantly — this creates a best-case scenario for compounding growth.)

Portfolio Growth Over Time

Data last updated: October 16, 2025 8:12 pm

Year-by-Year Portfolio Growth (Realistic DRIP Scenario)

Year	Start Balance	Start Shares	Share Price	Dividend / Share	Dividend Yield	Yield on Cost	Annual Dividend	Total Dividends	End Shares	End Balance
1	$10,000	24	$419.79	$0.72	0.69%	0.69%	$74	$74	27	$11,274
2	$13,409	27	$499.28	$0.77	0.62%	0.74%	$88	$162	29	$14,697
3	$17,480	29	$593.83	$0.83	0.56%	0.79%	$102	$264	32	$18,782
4	$22,339	32	$706.28	$0.89	0.51%	0.85%	$117	$381	33	$23,656
5	$28,136	33	$840.03	$0.96	0.46%	0.92%	$132	$514	35	$29,468
6	$35,048	35	$999.10	$1.03	0.41%	0.98%	$148	$662	36	$36,397
7	$43,289	36	$1,188.30	$1.11	0.37%	1.06%	$165	$827	38	$44,654
8	$53,110	38	$1,413.32	$1.19	0.34%	1.14%	$182	$1,009	39	$54,492
9	$64,810	39	$1,680.96	$1.28	0.31%	1.22%	$200	$1,209	39	$66,211
10	$78,749	39	$1,999.27	$1.38	0.28%	1.31%	$219	$1,429	40	$80,168

HCA Dividend History

Ex-Date	Payment Date	Amount	TTM Yield	Forward Yield	Price on Ex-Date
09/16/2025	09/16/2025	$0.720	0.71%	0.72%	$399.75
06/16/2025	06/16/2025	$0.720	0.75%	0.78%	$368.59
03/17/2025	03/17/2025	$0.720	0.82%	0.88%	$328.46
12/13/2024	12/13/2024	$0.660	0.84%	0.84%	$313.93
09/16/2024	09/16/2024	$0.660	0.64%	0.65%	$403.43
06/14/2024	06/14/2024	$0.660	0.75%	0.78%	$337.47
03/14/2024	03/14/2024	$0.660	0.76%	0.81%	$324.78
12/13/2023	12/13/2023	$0.600	0.89%	0.89%	$268.27
09/14/2023	09/14/2023	$0.600	0.90%	0.91%	$263.58
06/15/2023	06/15/2023	$0.600	0.81%	0.84%	$285.89
03/16/2023	03/16/2023	$0.600	0.90%	0.94%	$254.38
12/13/2022	12/13/2022	$0.560	0.92%	0.92%	$243.10
09/15/2022	09/15/2022	$0.560	1.03%	1.07%	$208.97
06/15/2022	06/15/2022	$0.560	1.14%	1.23%	$181.69
03/16/2022	03/16/2022	$0.560	0.75%	0.84%	$266.35
12/13/2021	12/13/2021	$0.480	0.79%	0.79%	$244.10
09/15/2021	09/15/2021	$0.480	0.67%	0.75%	$256.45
06/15/2021	06/15/2021	$0.480	0.62%	0.92%	$209.56
03/16/2021	03/16/2021	$0.480	0.67%	1.03%	$185.52
12/24/2020	12/24/2020	$0.268	0.71%	0.65%	$164.24

Page 1 of 1

HCA 10-yr Total Return ($10,000 invested)

This analysis of HCA demonstrates the power of dividend reinvestment over a 10-year period with a $10,000 initial investment. The dividend reinvestment strategy delivered a 21.4% CAGR, representing exceptional long-term performance. Recent 5-year performance has been particularly strong at 27.9% annually, outpacing the 10-year average. The DRIP strategy provided 18% more total return compared to collecting dividends as cash, highlighting the compounding effect of reinvestment.

With DRIP No DRIP

Date	With DRIP	No DRIP	DRIP Advantage	Dividend
2018-02-28	$10,035	$10,035	$0	$0.350
2018-05-31	$10,464	$10,462	$2	$0.350
2018-08-31	$13,642	$13,618	$23	$0.350
2018-11-30	$14,682	$14,649	$33	$0.350
2019-02-28	$14,218	$14,190	$28	$0.400
2019-05-31	$12,410	$12,409	$1	$0.400
2019-08-30	$12,373	$12,373	$0	$0.400
2019-11-29	$14,315	$14,273	$42	$0.400
2020-02-28	$13,156	$13,143	$14	$0.430
2020-10-29	$12,997	$12,988	$9	$0.072
2020-12-24	$17,050	$16,928	$122	$0.268
2021-03-16	$19,309	$19,120	$189	$0.480
2021-06-15	$21,862	$21,591	$271	$0.480
2021-09-15	$26,803	$26,364	$439	$0.480
2021-12-13	$25,563	$25,168	$395	$0.480
2022-03-16	$27,951	$27,466	$485	$0.560
2022-06-15	$19,126	$18,992	$133	$0.560
2022-09-15	$22,056	$21,797	$259	$0.560
2022-12-13	$25,718	$25,293	$425	$0.560
2023-03-16	$26,975	$26,490	$485	$0.600
2023-06-15	$30,379	$29,725	$655	$0.600
2023-09-14	$28,073	$27,538	$535	$0.600
2023-12-13	$28,636	$28,071	$565	$0.600
2024-03-14	$34,738	$33,831	$908	$0.660
2024-06-14	$36,166	$35,176	$991	$0.660
2024-09-16	$43,306	$41,888	$1,418	$0.660
2024-12-13	$33,769	$32,937	$832	$0.660
2025-03-17	$35,410	$34,474	$936	$0.720
2025-06-16	$39,814	$38,589	$1,224	$0.720
2025-09-16	$43,257	$41,802	$1,456	$0.720

Total Return with and without DRIP (HCA)

Over the selected period, investing $10,000 in HCA would grow to $46,423 with DRIP (364.2%), and $44,748 without DRIP (347.5%).

HCA Dividend Reinvestment Snowball

Investing $10,000 + $100/mo in HCA with historic price growth (18.93%) and dividend growth (7.48%) produces dramatically different outcomes depending on whether you reinvest dividends.

After 20 Years

Your Investment: $34,000

With DRIP

Portfolio: $563,198

Annual Dividend: $510

Yield on Cost: 1.50%

Total Dividends: $4,821

No DRIP

Portfolio: $541,722

Total Dividends: $4,646

After 30 Years

Your Investment: $46,000

With DRIP

Portfolio: $3,238,798

Annual Dividend: $1,066

Yield on Cost: 2.32%

Total Dividends: $12,110

No DRIP

Portfolio: $3,084,919

Total Dividends: $11,575

Milestones on the way

By year 13, the compounding really starts to show. Your total dividends collected reach $2,154 against a total investment of $25,600. At this point, your portfolio is throwing off $296 per year in dividends alone.

By year 17, the annual dividend climbs to around your initial contribution. For a starting investment of $10,000, the yearly dividend now sits at approximately $406, a powerful “income on autopilot” milestone.

After two decades, cumulative dividends total $4,821 versus $34,000 invested, nearly a 14% recovery of capital purely from income. Yield on cost reaches 1.50%.

At year 25, the income engine takes over. The portfolio’s annual dividend of $740 is greater than total contributions to date ($40,000), and cumulative dividends exceed $7,803.

By year 30, the DRIP snowball is in full force. Yearly income reaches $1,066, cumulative dividends total $12,110, and the DRIP portfolio value stands at $3,238,798, compared with $3,084,919 if dividends weren’t reinvested.

How we estimate these numbers

We use the latest calculator inputs for HCA, price $419.60, dividend per period $0.72 (4×/year), along with historic growth assumptions: price growth 18.93% and dividend growth 7.48% annually.

We simulate month by month for 30 years. Every month, a $100 contribution is added and converted to shares at that month’s price. Dividends are paid roughly evenly across the year based on the dividend frequency; in the DRIP path, each payout immediately buys additional shares at the then-current price. In the No‑DRIP path, dividends accrue as cash. Prices grow using a monthly rate derived from the annual price growth. Dividends per share increase once per year at the annual dividend growth rate.

This model isn’t investment advice; it’s a simple, transparent framework that illustrates how reinvesting dividends can accelerate both income and total return over time.

Projected Future Returns & Dividends for HCA

Based on past 10-year performance, here are HCA growth metrics:

Share price CAGR of +12.47%

Dividend CAGR of +-8.01%

Using HCA CAGR metrics, we can estimate that your initial $10,000 investment, over the next 10 years, should grow as follows:

	HCA (DRIP)	HCA (No DRIP)
Current Price	$418.74	$418.74
Start Shares	23.88	23.88
Start Value	$10,000	$10,000
After 10 years:
Final Share Count	24.53	23.88
Dividends Payment	$1.25	$1.25
Annual Dividends	$31	$30
Yield on cost	0.31%	0.30%
Share Price	$1,356.61	$1,356.61
Total Dividends	$454	$447
Final Value	$33,274	$32,844

Estimated Future Value + Dividends – HCA

Dividend History: Payments & Yield

Shows quarterly dividend payments with trailing yield and a 5-year rolling average overlay. Use the range pills to switch the visible period.

Yield Dividend

Date	Dividend	Share Price	Yield %	TTM Dividend	TTM Yield %
2018-02-28	$0.3500	$99.25	0.35%	$0.3500	0.35%
2018-05-31	$0.3500	$103.14	0.34%	$0.7000	0.68%
2018-08-31	$0.3500	$134.11	0.26%	$1.0500	0.78%
2018-11-30	$0.3500	$143.99	0.24%	$1.4000	0.97%
2019-02-28	$0.4000	$139.04	0.29%	$1.4500	1.04%
2019-05-31	$0.4000	$120.96	0.33%	$1.5000	1.24%
2019-08-30	$0.4000	$120.20	0.33%	$1.5500	1.29%
2019-11-29	$0.4000	$138.66	0.29%	$1.6000	1.15%
2020-02-28	$0.4300	$127.01	0.34%	$1.6300	1.28%
2020-10-29	$0.0720	$125.40	0.06%	$1.3020	1.04%
2020-12-24	$0.2680	$164.24	0.16%	$1.1700	0.71%
2021-03-16	$0.4800	$185.52	0.26%	$1.2500	0.67%
2021-06-15	$0.4800	$209.56	0.23%	$1.3000	0.62%
2021-09-15	$0.4800	$256.45	0.19%	$1.7080	0.67%
2021-12-13	$0.4800	$244.10	0.20%	$1.9200	0.79%
2022-03-16	$0.5600	$266.35	0.21%	$2.0000	0.75%
2022-06-15	$0.5600	$181.69	0.31%	$2.0800	1.14%
2022-09-15	$0.5600	$208.97	0.27%	$2.1600	1.03%
2022-12-13	$0.5600	$243.10	0.23%	$2.2400	0.92%
2023-03-16	$0.6000	$254.38	0.24%	$2.2800	0.90%
2023-06-15	$0.6000	$285.89	0.21%	$2.3200	0.81%
2023-09-14	$0.6000	$263.58	0.23%	$2.3600	0.90%
2023-12-13	$0.6000	$268.27	0.22%	$2.4000	0.89%
2024-03-14	$0.6600	$324.78	0.20%	$2.4600	0.76%
2024-06-14	$0.6600	$337.47	0.20%	$2.5200	0.75%
2024-09-16	$0.6600	$403.43	0.16%	$2.5800	0.64%
2024-12-13	$0.6600	$313.93	0.21%	$2.6400	0.84%
2025-03-17	$0.7200	$328.46	0.22%	$2.7000	0.82%
2025-06-16	$0.7200	$368.59	0.20%	$2.7600	0.75%
2025-09-16	$0.7200	$399.75	0.18%	$2.8200	0.71%

Dividend Growth

Lifetime quarterly dividend amounts, with range controls for 1Y/2Y/5Y/10Y. Useful to visualize the cadence and pace of dividend increases over time.

Dividend

Date	Dividend	Share Price	Yield %	QoQ Change
2018-02-28	$0.3500	$99.25	0.35%	N/A
2018-05-31	$0.3500	$103.14	0.34%	+0.0%
2018-08-31	$0.3500	$134.11	0.26%	+0.0%
2018-11-30	$0.3500	$143.99	0.24%	+0.0%
2019-02-28	$0.4000	$139.04	0.29%	+14.3%
2019-05-31	$0.4000	$120.96	0.33%	+0.0%
2019-08-30	$0.4000	$120.20	0.33%	+0.0%
2019-11-29	$0.4000	$138.66	0.29%	+0.0%
2020-02-28	$0.4300	$127.01	0.34%	+7.5%
2020-10-29	$0.0720	$125.40	0.06%	-83.3%
2020-12-24	$0.2680	$164.24	0.16%	+272.2%
2021-03-16	$0.4800	$185.52	0.26%	+79.1%
2021-06-15	$0.4800	$209.56	0.23%	+0.0%
2021-09-15	$0.4800	$256.45	0.19%	+0.0%
2021-12-13	$0.4800	$244.10	0.20%	+0.0%
2022-03-16	$0.5600	$266.35	0.21%	+16.7%
2022-06-15	$0.5600	$181.69	0.31%	+0.0%
2022-09-15	$0.5600	$208.97	0.27%	+0.0%
2022-12-13	$0.5600	$243.10	0.23%	+0.0%
2023-03-16	$0.6000	$254.38	0.24%	+7.1%
2023-06-15	$0.6000	$285.89	0.21%	+0.0%
2023-09-14	$0.6000	$263.58	0.23%	+0.0%
2023-12-13	$0.6000	$268.27	0.22%	+0.0%
2024-03-14	$0.6600	$324.78	0.20%	+10.0%
2024-06-14	$0.6600	$337.47	0.20%	+0.0%
2024-09-16	$0.6600	$403.43	0.16%	+0.0%
2024-12-13	$0.6600	$313.93	0.21%	+0.0%
2025-03-17	$0.7200	$328.46	0.22%	+9.1%
2025-06-16	$0.7200	$368.59	0.20%	+0.0%
2025-09-16	$0.7200	$399.75	0.18%	+0.0%

Dividend Payments & Yield

Quarterly dividends with TTM yield and a 5‑year rolling average overlay. Helps compare current yield versus recent history across different ranges.

Dividend 5-yr Rolling AVG Yield

Date	Dividend	TTM Yield	5-yr Avg Yield	YoY Change
2018-02-28	$0.3500	0.35%	0.35%	N/A
2018-05-31	$0.3500	0.68%	0.52%	N/A
2018-08-31	$0.3500	0.78%	0.60%	N/A
2018-11-30	$0.3500	0.97%	0.70%	N/A
2019-02-28	$0.4000	1.04%	0.77%	314.3%
2019-05-31	$0.4000	1.24%	0.84%	114.3%
2019-08-30	$0.4000	1.29%	0.91%	47.6%
2019-11-29	$0.4000	1.15%	0.94%	14.3%
2020-02-28	$0.4300	1.28%	0.98%	12.4%
2020-10-29	$0.0720	1.04%	0.98%	-13.2%
2020-12-24	$0.2680	0.71%	0.96%	-24.5%
2021-03-16	$0.4800	0.67%	0.94%	-21.9%
2021-06-15	$0.4800	0.62%	0.91%	-20.3%
2021-09-15	$0.4800	0.67%	0.89%	31.2%
2021-12-13	$0.4800	0.79%	0.89%	64.1%
2022-03-16	$0.5600	0.75%	0.88%	60.0%
2022-06-15	$0.5600	1.14%	0.89%	60.0%
2022-09-15	$0.5600	1.03%	0.90%	26.5%
2022-12-13	$0.5600	0.92%	0.90%	16.7%
2023-03-16	$0.6000	0.90%	0.90%	14.0%
2023-06-15	$0.6000	0.81%	0.92%	11.5%
2023-09-14	$0.6000	0.90%	0.94%	9.3%
2023-12-13	$0.6000	0.89%	0.94%	7.1%
2024-03-14	$0.6600	0.76%	0.93%	7.9%
2024-06-14	$0.6600	0.75%	0.92%	8.6%
2024-09-16	$0.6600	0.64%	0.89%	9.3%
2024-12-13	$0.6600	0.84%	0.86%	10.0%
2025-03-17	$0.7200	0.82%	0.85%	9.8%
2025-06-16	$0.7200	0.75%	0.82%	9.5%
2025-09-16	$0.7200	0.71%	0.80%	9.3%

HCA Dividend History

Ex-Date	Payment Date	Amount	TTM Yield	Forward Yield	Price on Ex-Date
09/16/2025	09/16/2025	$0.720	0.71%	0.72%	$399.75
06/16/2025	06/16/2025	$0.720	0.75%	0.78%	$368.59
03/17/2025	03/17/2025	$0.720	0.82%	0.88%	$328.46
12/13/2024	12/13/2024	$0.660	0.84%	0.84%	$313.93
09/16/2024	09/16/2024	$0.660	0.64%	0.65%	$403.43
06/14/2024	06/14/2024	$0.660	0.75%	0.78%	$337.47
03/14/2024	03/14/2024	$0.660	0.76%	0.81%	$324.78
12/13/2023	12/13/2023	$0.600	0.89%	0.89%	$268.27
09/14/2023	09/14/2023	$0.600	0.90%	0.91%	$263.58
06/15/2023	06/15/2023	$0.600	0.81%	0.84%	$285.89
03/16/2023	03/16/2023	$0.600	0.90%	0.94%	$254.38
12/13/2022	12/13/2022	$0.560	0.92%	0.92%	$243.10
09/15/2022	09/15/2022	$0.560	1.03%	1.07%	$208.97
06/15/2022	06/15/2022	$0.560	1.14%	1.23%	$181.69
03/16/2022	03/16/2022	$0.560	0.75%	0.84%	$266.35
12/13/2021	12/13/2021	$0.480	0.79%	0.79%	$244.10
09/15/2021	09/15/2021	$0.480	0.67%	0.75%	$256.45
06/15/2021	06/15/2021	$0.480	0.62%	0.92%	$209.56
03/16/2021	03/16/2021	$0.480	0.67%	1.03%	$185.52
12/24/2020	12/24/2020	$0.268	0.71%	0.65%	$164.24
10/29/2020	10/29/2020	$0.072	1.04%	0.23%	$125.40
02/28/2020	02/28/2020	$0.430	1.28%	1.35%	$127.01
11/29/2019	11/29/2019	$0.400	1.15%	1.15%	$138.66
08/30/2019	08/30/2019	$0.400	1.29%	1.33%	$120.20
05/31/2019	05/31/2019	$0.400	1.24%	1.32%	$120.96
02/28/2019	02/28/2019	$0.400	1.04%	1.15%	$139.04
11/30/2018	11/30/2018	$0.350	0.97%	0.97%	$143.99
08/31/2018	08/31/2018	$0.350	2.27%	1.04%	$134.11
05/31/2018	05/31/2018	$0.350	5.04%	1.36%	$103.14
02/28/2018	02/28/2018	$0.350	6.90%	1.41%	$99.25
12/13/2012	12/13/2012	$2.00	21.07%	25.93%	$30.85
10/31/2012	10/31/2012	$2.50	15.84%	35.20%	$28.41
02/14/2012	02/14/2012	$2.00	7.97%	31.89%	$25.09

Page 1 of 1

Dividend Payout Ratio

Tracks the percentage of earnings paid out as dividends each quarter. Lower and stable ratios often indicate safer, more sustainable payouts.

Payout Ratio

Date	Payout Ratio	QoQ Change	YoY Change
2021-10-31	5.7%	N/A	N/A
2022-01-31	6.8%	+17.5%	N/A
2022-04-30	7.4%	+9.3%	N/A
2022-07-31	8.1%	+9.9%	N/A
2022-10-31	9.0%	+10.4%	+55.9%
2023-01-31	9.4%	+5.4%	+39.9%
2023-04-30	9.8%	+3.6%	+32.5%
2023-07-31	10.1%	+3.7%	+25.0%
2023-10-31	10.5%	+3.8%	+17.6%
2024-01-31	10.5%	-0.6%	+10.9%
2024-04-30	10.5%	+0.2%	+7.3%
2024-07-31	10.5%	0.0%	+3.4%
2024-10-31	10.5%	-0.1%	-0.5%
2025-06-30	6.2%	-40.8%	-40.8%

Dividend to Free Cash Flow Ratio

Shows dividends as a percentage of free cash flow. Consistently high values may signal limited reinvestment capacity or potential dividend risk.

Dividend/FCF Ratio

Date	Dividend/FCF Ratio	QoQ Change	YoY Change
2021-01-31	15.0%	N/A	N/A
2021-04-30	13.9%	-7.1%	N/A
2021-07-31	19.5%	+40.6%	N/A
2021-10-31	23.1%	+18.0%	N/A
2022-01-31	36.4%	+57.8%	+143.2%
2022-04-30	33.1%	-9.1%	+137.9%
2022-07-31	30.5%	-7.8%	+56.1%
2022-10-31	28.4%	-6.7%	+23.4%
2023-01-31	39.4%	+38.4%	+8.2%
2023-04-30	34.9%	-11.2%	+5.7%
2023-07-31	31.5%	-9.8%	+3.4%
2023-10-31	28.8%	-8.6%	+1.3%
2024-01-31	38.8%	+34.7%	-1.4%
2024-04-30	34.7%	-10.6%	-0.7%
2024-07-31	31.5%	-9.2%	0.0%
2024-10-31	29.0%	-8.0%	+0.6%
2025-10-17	6.5%	-77.6%	-83.2%

Share Price

Historical closing price with range controls. Table view includes quarter‑over‑quarter and year‑over‑year changes for additional context.

HCA Price

Date	Share Price	Price Change	QoQ Change	YoY Change
2018-02-28	$99.25	N/A	N/A	N/A
2018-05-31	$103.14	+$3.89	0.0%	N/A
2018-08-31	$134.11	+$30.97	0.0%	N/A
2018-11-30	$143.99	+$9.88	0.0%	N/A
2019-02-28	$139.04	$-4.95	14.3%	14.3%
2019-05-31	$120.96	$-18.08	0.0%	14.3%
2019-08-30	$120.20	$-0.76	0.0%	14.3%
2019-11-29	$138.66	+$18.46	0.0%	14.3%
2020-02-28	$127.01	$-11.65	7.5%	7.5%
2020-10-29	$125.40	$-1.61	-83.3%	-82.0%
2020-12-24	$164.24	+$38.84	272.2%	-33.0%
2021-03-16	$185.52	+$21.28	79.1%	20.0%
2021-06-15	$209.56	+$24.04	0.0%	11.6%
2021-09-15	$256.45	+$46.89	0.0%	566.7%
2021-12-13	$244.10	$-12.35	0.0%	79.1%
2022-03-16	$266.35	+$22.25	16.7%	16.7%
2022-06-15	$181.69	$-84.66	0.0%	16.7%
2022-09-15	$208.97	+$27.28	0.0%	16.7%
2022-12-13	$243.10	+$34.13	0.0%	16.7%
2023-03-16	$254.38	+$11.28	7.1%	7.1%
2023-06-15	$285.89	+$31.51	0.0%	7.1%
2023-09-14	$263.58	$-22.31	0.0%	7.1%
2023-12-13	$268.27	+$4.69	0.0%	7.1%
2024-03-14	$324.78	+$56.51	10.0%	10.0%
2024-06-14	$337.47	+$12.69	0.0%	10.0%
2024-09-16	$403.43	+$65.96	0.0%	10.0%
2024-12-13	$313.93	$-89.50	0.0%	10.0%
2025-03-17	$328.46	+$14.53	9.1%	9.1%
2025-06-16	$368.59	+$40.13	0.0%	9.1%
2025-09-16	$399.75	+$31.16	0.0%	9.1%

Price to Earnings

HCA trades at a 48.8x price-to-earnings ratio. This elevated valuation suggests investors expect strong future growth.

2021-01-31	22.1x	N/A	Q-Est
2021-04-30	23.1x	+4.6%	Q-Est
2021-07-31	27.8x	+20.2%	Q-Est
2021-10-31	32.7x	+17.4%	Q-Est
2022-01-31	42.6x	+30.5%	Q-Est
2022-04-30	41.5x	-2.6%	Q-Est
2022-07-31	27.9x	-32.9%	Q-Est
2022-10-31	30.5x	+9.4%	Q-Est
2023-01-31	42.8x	+40.5%	Q-Est
2023-04-30	43.5x	+1.5%	Q-Est
2023-07-31	54.2x	+24.7%	Q-Est
2023-10-31	43.9x	-18.9%	Q-Est
2024-01-31	44.0x	+0.1%	Q-Est
2024-04-30	50.6x	+15.2%	Q-Est
2024-07-31	52.2x	+3.1%	Q-Est
2024-09-30	72.9x	+39.6%	Q
2024-10-31	66.0x	-9.4%	Q-Est
2024-12-31	53.2x	-19.4%	Q
2025-03-31	47.9x	-9.9%	Q
2025-06-30	48.8x	+1.9%	Q

Price to Sales

HCA trades at a 4.3x price-to-sales ratio, providing insight into market valuation relative to revenue generation.

2021-01-31	2.6x	N/A	Q-Est
2021-04-30	2.7x	+4.6%	Q-Est
2021-07-31	3.3x	+20.2%	Q-Est
2021-10-31	3.9x	+17.4%	Q-Est
2022-01-31	4.0x	+3.2%	Q-Est
2022-04-30	3.9x	-2.6%	Q-Est
2022-07-31	2.6x	-32.9%	Q-Est
2022-10-31	2.9x	+9.4%	Q-Est
2023-01-31	3.5x	+21.0%	Q-Est
2023-04-30	3.5x	+1.5%	Q-Est
2023-07-31	4.4x	+24.7%	Q-Est
2023-10-31	3.5x	-18.9%	Q-Est
2024-01-31	3.6x	+1.3%	Q-Est
2024-04-30	4.1x	+15.2%	Q-Est
2024-07-31	4.3x	+3.1%	Q-Est
2024-09-30	5.3x	+24.3%	Q
2024-10-31	5.4x	+1.8%	Q-Est
2024-12-31	4.2x	-22.3%	Q
2025-03-31	4.2x	+0.6%	Q
2025-06-30	4.3x	+3.0%	Q

Revenue

HCA generated $18.6B in revenue. Revenue has grown by 27% over the period.

2021-01-31	$14.69B	N/A	Q-Est
2021-04-30	$14.69B	+0.0%	Q-Est
2021-07-31	$14.69B	+0.0%	Q-Est
2021-10-31	$14.69B	+0.0%	Q-Est
2022-01-31	$15.06B	+2.5%	Q-Est
2022-04-30	$15.06B	+0.0%	Q-Est
2022-07-31	$15.06B	+0.0%	Q-Est
2022-10-31	$15.06B	+0.0%	Q-Est
2023-01-31	$16.24B	+7.9%	Q-Est
2023-04-30	$16.24B	+0.0%	Q-Est
2023-07-31	$16.24B	+0.0%	Q-Est
2023-10-31	$16.24B	+0.0%	Q-Est
2024-01-31	$17.65B	+8.7%	Q-Est
2024-04-30	$17.65B	+0.0%	Q-Est
2024-07-31	$17.65B	+0.0%	Q-Est
2024-09-30	$17.49B	-0.9%	Q
2024-10-31	$17.65B	+0.9%	Q-Est
2024-12-31	$18.29B	+3.6%	Q
2025-03-31	$18.32B	+0.2%	Q
2025-06-30	$18.61B	+1.6%	Q

Net Income

HCA reported $1.7B in net income.

2021-01-31	$1.74B	N/A	Q-Est
2021-04-30	$1.74B	+0.0%	Q-Est
2021-07-31	$1.74B	+0.0%	Q-Est
2021-10-31	$1.74B	+0.0%	Q-Est
2022-01-31	$1.41B	-18.9%	Q-Est
2022-04-30	$1.41B	+0.0%	Q-Est
2022-07-31	$1.41B	+0.0%	Q-Est
2022-10-31	$1.41B	+0.0%	Q-Est
2023-01-31	$1.31B	-7.1%	Q-Est
2023-04-30	$1.31B	+0.0%	Q-Est
2023-07-31	$1.31B	+0.0%	Q-Est
2023-10-31	$1.31B	+0.0%	Q-Est
2024-01-31	$1.44B	+9.9%	Q-Est
2024-04-30	$1.44B	+0.0%	Q-Est
2024-07-31	$1.44B	+0.0%	Q-Est
2024-09-30	$1.27B	-11.8%	Q
2024-10-31	$1.44B	+13.4%	Q-Est
2024-12-31	$1.44B	-0.1%	Q
2025-03-31	$1.61B	+12.0%	Q
2025-06-30	$1.65B	+2.7%	Q

Revenue vs Net Income

HCA generated $18.6B in revenue with net income of $1.7B, representing a 8.9% net profit margin.

2021-01-31	$14.69B	$1.74B	Q-Est
2021-04-30	$14.69B	$1.74B	Q-Est
2021-07-31	$14.69B	$1.74B	Q-Est
2021-10-31	$14.69B	$1.74B	Q-Est
2022-01-31	$15.06B	$1.41B	Q-Est
2022-04-30	$15.06B	$1.41B	Q-Est
2022-07-31	$15.06B	$1.41B	Q-Est
2022-10-31	$15.06B	$1.41B	Q-Est
2023-01-31	$16.24B	$1.31B	Q-Est
2023-04-30	$16.24B	$1.31B	Q-Est
2023-07-31	$16.24B	$1.31B	Q-Est
2023-10-31	$16.24B	$1.31B	Q-Est
2024-01-31	$17.65B	$1.44B	Q-Est
2024-04-30	$17.65B	$1.44B	Q-Est
2024-07-31	$17.65B	$1.44B	Q-Est
2024-09-30	$17.49B	$1.27B	Q
2024-10-31	$17.65B	$1.44B	Q-Est
2024-12-31	$18.29B	$1.44B	Q
2025-03-31	$18.32B	$1.61B	Q
2025-06-30	$18.61B	$1.65B	Q

Gross Profit

HCA achieved $14.9B in gross profit, showing revenue after direct production costs.

2021-01-31	$9.76B	N/A	Q-Est
2021-04-30	$10.11B	+3.6%	Q-Est
2021-07-31	$9.98B	-1.3%	Q-Est
2021-10-31	$10.36B	+3.9%	Q-Est
2022-01-31	$9.95B	-4.0%	Q-Est
2022-04-30	$10.35B	+4.0%	Q-Est
2022-07-31	$10.92B	+5.6%	Q-Est
2022-10-31	$9.90B	-9.4%	Q-Est
2023-01-31	$12.53B	+26.5%	Q-Est
2023-04-30	$12.41B	-0.9%	Q-Est
2023-07-31	$13.32B	+7.3%	Q-Est
2023-10-31	$12.35B	-7.3%	Q-Est
2024-01-31	$14.03B	+13.6%	Q-Est
2024-04-30	$13.25B	-5.5%	Q-Est
2024-07-31	$13.37B	+0.9%	Q-Est
2024-09-30	$14.08B	+5.3%	Q-Est
2024-10-31	$13.95B	-0.9%	Q-Est
2024-12-31	$14.65B	+5.1%	Q-Est
2025-03-31	$14.59B	-0.4%	Q-Est
2025-06-30	$14.88B	+2.0%	Q-Est

Operating Income

HCA generated $6.5B in operating income, representing profit from core business operations.

2021-01-31	$5.14B	N/A	Q-Est
2021-04-30	$5.14B	+0.0%	Q-Est
2021-07-31	$5.14B	+0.0%	Q-Est
2021-10-31	$5.14B	+0.0%	Q-Est
2022-01-31	$5.27B	+2.5%	Q-Est
2022-04-30	$5.27B	+0.0%	Q-Est
2022-07-31	$5.27B	+0.0%	Q-Est
2022-10-31	$5.27B	+0.0%	Q-Est
2023-01-31	$5.68B	+7.9%	Q-Est
2023-04-30	$5.68B	+0.0%	Q-Est
2023-07-31	$5.68B	+0.0%	Q-Est
2023-10-31	$5.68B	+0.0%	Q-Est
2024-01-31	$6.18B	+8.7%	Q-Est
2024-04-30	$6.18B	+0.0%	Q-Est
2024-07-31	$6.18B	+0.0%	Q-Est
2024-09-30	$6.12B	-0.9%	Q-Est
2024-10-31	$6.18B	+0.9%	Q-Est
2024-12-31	$6.40B	+3.6%	Q-Est
2025-03-31	$6.41B	+0.2%	Q-Est
2025-06-30	$6.51B	+1.6%	Q-Est

EBITDA

HCA generated $7.5B in EBITDA, measuring operational profitability before interest, taxes, depreciation, and amortization.

2021-01-31	$5.91B	N/A	Q-Est
2021-04-30	$5.91B	+0.0%	Q-Est
2021-07-31	$5.91B	+0.0%	Q-Est
2021-10-31	$5.91B	+0.0%	Q-Est
2022-01-31	$6.06B	+2.5%	Q-Est
2022-04-30	$6.06B	+0.0%	Q-Est
2022-07-31	$6.06B	+0.0%	Q-Est
2022-10-31	$6.06B	+0.0%	Q-Est
2023-01-31	$6.54B	+7.9%	Q-Est
2023-04-30	$6.54B	+0.0%	Q-Est
2023-07-31	$6.54B	+0.0%	Q-Est
2023-10-31	$6.54B	+0.0%	Q-Est
2024-01-31	$7.10B	+8.7%	Q-Est
2024-04-30	$7.10B	+0.0%	Q-Est
2024-07-31	$7.10B	+0.0%	Q-Est
2024-09-30	$7.04B	-0.9%	Q-Est
2024-10-31	$7.10B	+0.9%	Q-Est
2024-12-31	$7.36B	+3.6%	Q-Est
2025-03-31	$7.37B	+0.2%	Q-Est
2025-06-30	$7.49B	+1.6%	Q-Est

Operating Cash Flow

HCA generated $1.9B in operating cash flow, demonstrating the company’s ability to convert earnings into cash.

2021-01-31	$2.00B	N/A	Q-Est
2021-04-30	$2.00B	+0.0%	Q-Est
2021-07-31	$2.00B	+0.0%	Q-Est
2021-10-31	$2.00B	+0.0%	Q-Est
2022-01-31	$1.62B	-18.9%	Q-Est
2022-04-30	$1.62B	+0.0%	Q-Est
2022-07-31	$1.62B	+0.0%	Q-Est
2022-10-31	$1.62B	+0.0%	Q-Est
2023-01-31	$1.51B	-7.1%	Q-Est
2023-04-30	$1.51B	+0.0%	Q-Est
2023-07-31	$1.51B	+0.0%	Q-Est
2023-10-31	$1.51B	+0.0%	Q-Est
2024-01-31	$1.66B	+9.9%	Q-Est
2024-04-30	$1.66B	+0.0%	Q-Est
2024-07-31	$1.66B	+0.0%	Q-Est
2024-09-30	$1.46B	-11.8%	Q-Est
2024-10-31	$1.66B	+13.4%	Q-Est
2024-12-31	$1.65B	-0.1%	Q-Est
2025-03-31	$1.85B	+12.0%	Q-Est
2025-06-30	$1.90B	+2.7%	Q-Est

Free Cash Flow

HCA generated $1.2B in free cash flow. Free cash flow has decreased by 16% over the period.

2021-01-31	$1.49B	N/A	Q-Est
2021-04-30	$1.49B	+0.0%	Q-Est
2021-07-31	$1.49B	+0.0%	Q-Est
2021-10-31	$1.49B	+0.0%	Q-Est
2022-01-31	$1.10B	-26.3%	Q-Est
2022-04-30	$1.10B	+0.0%	Q-Est
2022-07-31	$1.10B	+0.0%	Q-Est
2022-10-31	$1.10B	+0.0%	Q-Est
2023-01-31	$0.94B	-14.3%	Q-Est
2023-04-30	$0.94B	+0.0%	Q-Est
2023-07-31	$0.94B	+0.0%	Q-Est
2023-10-31	$0.94B	+0.0%	Q-Est
2024-01-31	$1.04B	+10.6%	Q-Est
2024-04-30	$1.04B	+0.0%	Q-Est
2024-07-31	$1.04B	+0.0%	Q-Est
2024-09-30	$0.85B	-18.3%	Q-Est
2024-10-31	$1.04B	+22.4%	Q-Est
2024-12-31	$1.01B	-2.4%	Q-Est
2025-03-31	$1.21B	+19.4%	Q-Est
2025-06-30	$1.25B	+3.3%	Q-Est

Free Cash Flow / Share

HCA generates $5.34 in free cash flow per share. FCF per share has declined by 16% over the period.

2021-01-31	$6.35	N/A	Q-Est
2021-04-30	$6.35	+0.0%	Q-Est
2021-07-31	$6.35	+0.0%	Q-Est
2021-10-31	$6.35	+0.0%	Q-Est
2022-01-31	$4.68	-26.3%	Q-Est
2022-04-30	$4.68	+0.0%	Q-Est
2022-07-31	$4.68	+0.0%	Q-Est
2022-10-31	$4.68	+0.0%	Q-Est
2023-01-31	$4.01	-14.3%	Q-Est
2023-04-30	$4.01	+0.0%	Q-Est
2023-07-31	$4.01	+0.0%	Q-Est
2023-10-31	$4.01	+0.0%	Q-Est
2024-01-31	$4.44	+10.6%	Q-Est
2024-04-30	$4.44	+0.0%	Q-Est
2024-07-31	$4.44	+0.0%	Q-Est
2024-09-30	$3.63	-18.3%	Q-Est
2024-10-31	$4.44	+22.4%	Q-Est
2024-12-31	$4.33	-2.4%	Q-Est
2025-03-31	$5.17	+19.4%	Q-Est
2025-06-30	$5.34	+3.3%	Q-Est

Earnings Per Share (EPS)

HCA reported $7.06 in earnings per share.

2021-01-31	$7.43	N/A	Q-Est
2021-04-30	$7.43	+0.0%	Q-Est
2021-07-31	$7.43	+0.0%	Q-Est
2021-10-31	$7.43	+0.0%	Q-Est
2022-01-31	$6.03	-18.9%	Q-Est
2022-04-30	$6.03	+0.0%	Q-Est
2022-07-31	$6.03	+0.0%	Q-Est
2022-10-31	$6.03	+0.0%	Q-Est
2023-01-31	$5.60	-7.1%	Q-Est
2023-04-30	$5.60	+0.0%	Q-Est
2023-07-31	$5.60	+0.0%	Q-Est
2023-10-31	$5.60	+0.0%	Q-Est
2024-01-31	$6.15	+9.9%	Q-Est
2024-04-30	$6.15	+0.0%	Q-Est
2024-07-31	$6.15	+0.0%	Q-Est
2024-09-30	$5.43	-11.8%	Q
2024-10-31	$6.15	+13.4%	Q-Est
2024-12-31	$6.15	-0.1%	Q
2025-03-31	$6.88	+12.0%	Q
2025-06-30	$7.06	+2.7%	Q

Return on Equity (ROE)

HCA delivered a 7.4% return on equity, indicating how effectively the company generates returns for shareholders.

2021-01-31	9.9%	N/A	Q-Est
2021-04-30	9.9%	+0.0%	Q-Est
2021-07-31	9.9%	+0.0%	Q-Est
2021-10-31	9.9%	+0.0%	Q-Est
2022-01-31	7.8%	-20.9%	Q-Est
2022-04-30	7.8%	+0.0%	Q-Est
2022-07-31	7.8%	+0.0%	Q-Est
2022-10-31	7.8%	+0.0%	Q-Est
2023-01-31	6.7%	-14.0%	Q-Est
2023-04-30	6.7%	+0.0%	Q-Est
2023-07-31	6.7%	+0.0%	Q-Est
2023-10-31	6.7%	+0.0%	Q-Est
2024-01-31	6.8%	+1.2%	Q-Est
2024-04-30	6.8%	+0.0%	Q-Est
2024-07-31	6.8%	+0.0%	Q-Est
2024-09-30	6.1%	-11.0%	Q-Est
2024-10-31	6.8%	+12.4%	Q-Est
2024-12-31	6.6%	-3.7%	Q-Est
2025-03-31	7.3%	+11.8%	Q-Est
2025-06-30	7.4%	+1.1%	Q-Est

Return on Assets (ROA)

HCA achieved a 4.4% return on assets, measuring how efficiently the company uses its assets to generate profit.

2021-01-31	5.9%	N/A	Q-Est
2021-04-30	5.9%	+0.0%	Q-Est
2021-07-31	5.9%	+0.0%	Q-Est
2021-10-31	5.9%	+0.0%	Q-Est
2022-01-31	4.7%	-20.9%	Q-Est
2022-04-30	4.7%	+0.0%	Q-Est
2022-07-31	4.7%	+0.0%	Q-Est
2022-10-31	4.7%	+0.0%	Q-Est
2023-01-31	4.0%	-13.9%	Q-Est
2023-04-30	4.0%	+0.0%	Q-Est
2023-07-31	4.0%	+0.0%	Q-Est
2023-10-31	4.0%	+0.0%	Q-Est
2024-01-31	4.1%	+1.2%	Q-Est
2024-04-30	4.1%	+0.0%	Q-Est
2024-07-31	4.1%	+0.0%	Q-Est
2024-09-30	3.6%	-11.0%	Q-Est
2024-10-31	4.1%	+12.4%	Q-Est
2024-12-31	3.9%	-3.7%	Q-Est
2025-03-31	4.4%	+11.7%	Q-Est
2025-06-30	4.4%	+1.1%	Q-Est

Net Profit Margin

HCA maintains a 8.9% net profit margin, showing the percentage of revenue retained as profit after all expenses.

2021-01-31	11.8%	N/A	Q-Est
2021-04-30	11.8%	+0.0%	Q-Est
2021-07-31	11.8%	+0.0%	Q-Est
2021-10-31	11.8%	+0.0%	Q-Est
2022-01-31	9.4%	-20.9%	Q-Est
2022-04-30	9.4%	+0.0%	Q-Est
2022-07-31	9.4%	+0.0%	Q-Est
2022-10-31	9.4%	+0.0%	Q-Est
2023-01-31	8.1%	-13.9%	Q-Est
2023-04-30	8.1%	+0.0%	Q-Est
2023-07-31	8.1%	+0.0%	Q-Est
2023-10-31	8.1%	+0.0%	Q-Est
2024-01-31	8.2%	+1.1%	Q-Est
2024-04-30	8.2%	+0.0%	Q-Est
2024-07-31	8.2%	+0.0%	Q-Est
2024-09-30	7.3%	-11.0%	Q
2024-10-31	8.2%	+12.3%	Q-Est
2024-12-31	7.9%	-3.6%	Q
2025-03-31	8.8%	+11.7%	Q
2025-06-30	8.9%	+1.1%	Q

Gross Profit Margin

HCA operates with a 80.0% gross profit margin, reflecting pricing power and cost efficiency in core operations.

2021-01-31	66.4%	N/A	Q-Est
2021-04-30	68.8%	+3.6%	Q-Est
2021-07-31	67.9%	-1.3%	Q-Est
2021-10-31	70.6%	+3.9%	Q-Est
2022-01-31	66.0%	-6.4%	Q-Est
2022-04-30	68.7%	+4.0%	Q-Est
2022-07-31	72.5%	+5.6%	Q-Est
2022-10-31	65.7%	-9.4%	Q-Est
2023-01-31	77.1%	+17.3%	Q-Est
2023-04-30	76.4%	-0.9%	Q-Est
2023-07-31	82.0%	+7.3%	Q-Est
2023-10-31	76.0%	-7.3%	Q-Est
2024-01-31	79.5%	+4.5%	Q-Est
2024-04-30	75.1%	-5.5%	Q-Est
2024-07-31	75.7%	+0.9%	Q-Est
2024-09-30	80.5%	+6.3%	Q
2024-10-31	79.0%	-1.9%	Q-Est
2024-12-31	80.1%	+1.4%	Q
2025-03-31	79.6%	-0.6%	Q
2025-06-30	80.0%	+0.4%	Q

Cash & Debt

HCA holds $2.8B in cash against $0.9B in debt, resulting in a net cash position of $1.9B.

2021-01-31	$2.20B	$0.73B	$1.47B	Q-Est
2021-04-30	$2.20B	$0.73B	$1.47B	Q-Est
2021-07-31	$2.20B	$0.73B	$1.47B	Q-Est
2021-10-31	$2.20B	$0.73B	$1.47B	Q-Est
2022-01-31	$2.26B	$0.75B	$1.51B	Q-Est
2022-04-30	$2.26B	$0.75B	$1.51B	Q-Est
2022-07-31	$2.26B	$0.75B	$1.51B	Q-Est
2022-10-31	$2.26B	$0.75B	$1.51B	Q-Est
2023-01-31	$2.44B	$0.81B	$1.62B	Q-Est
2023-04-30	$2.44B	$0.81B	$1.62B	Q-Est
2023-07-31	$2.44B	$0.81B	$1.62B	Q-Est
2023-10-31	$2.44B	$0.81B	$1.62B	Q-Est
2024-01-31	$2.65B	$0.88B	$1.77B	Q-Est
2024-04-30	$2.65B	$0.88B	$1.77B	Q-Est
2024-07-31	$2.65B	$0.88B	$1.77B	Q-Est
2024-09-30	$2.62B	$0.87B	$1.75B	Q-Est
2024-10-31	$2.65B	$0.88B	$1.77B	Q-Est
2024-12-31	$2.74B	$0.91B	$1.83B	Q-Est
2025-03-31	$2.75B	$0.92B	$1.83B	Q-Est
2025-06-30	$2.79B	$0.93B	$1.86B	Q-Est

Shares Outstanding

HCA has 0.2B shares outstanding.

2021-01-31	0.23B	N/A	Q-Est
2021-04-30	0.23B	+0.0%	Q-Est
2021-07-31	0.23B	+0.0%	Q-Est
2021-10-31	0.23B	+0.0%	Q-Est
2022-01-31	0.23B	+0.0%	Q-Est
2022-04-30	0.23B	+0.0%	Q-Est
2022-07-31	0.23B	+0.0%	Q-Est
2022-10-31	0.23B	+0.0%	Q-Est
2023-01-31	0.23B	+0.0%	Q-Est
2023-04-30	0.23B	+0.0%	Q-Est
2023-07-31	0.23B	+0.0%	Q-Est
2023-10-31	0.23B	+0.0%	Q-Est
2024-01-31	0.23B	+0.0%	Q-Est
2024-04-30	0.23B	+0.0%	Q-Est
2024-07-31	0.23B	+0.0%	Q-Est
2024-09-30	0.23B	+0.0%	Q-Est
2024-10-31	0.23B	+0.0%	Q-Est
2024-12-31	0.23B	+0.0%	Q-Est
2025-03-31	0.23B	+0.0%	Q-Est
2025-06-30	0.23B	+0.0%	Q-Est

Stock-Based Comp

HCA reported $0.5B in stock-based compensation. Over the period, stock-based compensation has increased by 27%.

2021-01-31	$0.37B	N/A	Q-Est
2021-04-30	$0.37B	+0.0%	Q-Est
2021-07-31	$0.37B	+0.0%	Q-Est
2021-10-31	$0.37B	+0.0%	Q-Est
2022-01-31	$0.38B	+2.5%	Q-Est
2022-04-30	$0.38B	+0.0%	Q-Est
2022-07-31	$0.38B	+0.0%	Q-Est
2022-10-31	$0.38B	+0.0%	Q-Est
2023-01-31	$0.41B	+7.9%	Q-Est
2023-04-30	$0.41B	+0.0%	Q-Est
2023-07-31	$0.41B	+0.0%	Q-Est
2023-10-31	$0.41B	+0.0%	Q-Est
2024-01-31	$0.44B	+8.7%	Q-Est
2024-04-30	$0.44B	+0.0%	Q-Est
2024-07-31	$0.44B	+0.0%	Q-Est
2024-09-30	$0.44B	-0.9%	Q-Est
2024-10-31	$0.44B	+0.9%	Q-Est
2024-12-31	$0.46B	+3.6%	Q-Est
2025-03-31	$0.46B	+0.2%	Q-Est
2025-06-30	$0.47B	+1.6%	Q-Est

FCF vs Stock Based Comp

HCA generated $1.2B in free cash flow while spending $0.5B on stock-based compensation, representing 37% of FCF.

2021-01-31	$1.49B	$0.37B	Q-Est
2021-04-30	$1.49B	$0.37B	Q-Est
2021-07-31	$1.49B	$0.37B	Q-Est
2021-10-31	$1.49B	$0.37B	Q-Est
2022-01-31	$1.10B	$0.38B	Q-Est
2022-04-30	$1.10B	$0.38B	Q-Est
2022-07-31	$1.10B	$0.38B	Q-Est
2022-10-31	$1.10B	$0.38B	Q-Est
2023-01-31	$0.94B	$0.41B	Q-Est
2023-04-30	$0.94B	$0.41B	Q-Est
2023-07-31	$0.94B	$0.41B	Q-Est
2023-10-31	$0.94B	$0.41B	Q-Est
2024-01-31	$1.04B	$0.44B	Q-Est
2024-04-30	$1.04B	$0.44B	Q-Est
2024-07-31	$1.04B	$0.44B	Q-Est
2024-09-30	$0.85B	$0.44B	Q-Est
2024-10-31	$1.04B	$0.44B	Q-Est
2024-12-31	$1.01B	$0.46B	Q-Est
2025-03-31	$1.21B	$0.46B	Q-Est
2025-06-30	$1.25B	$0.47B	Q-Est

FCF vs FCF / Share

HCA reported $1.2B in free cash flow, translating to $5.34 per share.

2021-01-31	$1.49B	$6.35	Q-Est
2021-04-30	$1.49B	$6.35	Q-Est
2021-07-31	$1.49B	$6.35	Q-Est
2021-10-31	$1.49B	$6.35	Q-Est
2022-01-31	$1.10B	$4.68	Q-Est
2022-04-30	$1.10B	$4.68	Q-Est
2022-07-31	$1.10B	$4.68	Q-Est
2022-10-31	$1.10B	$4.68	Q-Est
2023-01-31	$0.94B	$4.01	Q-Est
2023-04-30	$0.94B	$4.01	Q-Est
2023-07-31	$0.94B	$4.01	Q-Est
2023-10-31	$0.94B	$4.01	Q-Est
2024-01-31	$1.04B	$4.44	Q-Est
2024-04-30	$1.04B	$4.44	Q-Est
2024-07-31	$1.04B	$4.44	Q-Est
2024-09-30	$0.85B	$3.63	Q-Est
2024-10-31	$1.04B	$4.44	Q-Est
2024-12-31	$1.01B	$4.33	Q-Est
2025-03-31	$1.21B	$5.17	Q-Est
2025-06-30	$1.25B	$5.34	Q-Est

Revenue: Actual + Estimates

This chart tracks HCA revenue: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-01-31	$17.65B	Actual	Q-Est
2024-01-31	$17.30B	Estimate	Q-Est
2024-04-30	$17.65B	Actual	Q-Est
2024-04-30	$17.30B	Estimate	Q-Est
2024-07-31	$17.65B	Actual	Q-Est
2024-07-31	$17.30B	Estimate	Q-Est
2024-09-30	$17.49B	Actual	Q
2024-09-30	$17.14B	Estimate	Q
2024-10-31	$17.65B	Actual	Q-Est
2024-10-31	$17.30B	Estimate	Q-Est
2024-12-31	$18.29B	Actual	Q
2024-12-31	$17.92B	Estimate	Q
2025-03-31	$18.32B	Actual	Q
2025-03-31	$17.95B	Estimate	Q
2025-06-30	$18.61B	Actual	Q
2025-06-30	$18.23B	Estimate	Q
2025-09-30	$18.86B	Projection	F
2025-12-30	$19.12B	Projection	F
2026-03-30	$19.38B	Projection	F
2026-06-30	$19.65B	Projection	F

EPS: Actual + Estimates

This chart tracks HCA eps: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-01-31	$6.15	Actual	Q-Est
2024-01-31	$5.85	Estimate	Q-Est
2024-04-30	$6.15	Actual	Q-Est
2024-04-30	$5.85	Estimate	Q-Est
2024-07-31	$6.15	Actual	Q-Est
2024-07-31	$4.98	Estimate	Q-Est
2024-09-30	$6.15	Actual	Q-Est
2024-09-30	$4.98	Estimate	Q-Est
2024-10-31	$5.43	Actual	Q
2024-10-31	$4.98	Estimate	Q
2024-12-31	$6.15	Actual	Q-Est
2024-12-31	$6.14	Estimate	Q-Est
2025-03-31	$6.15	Actual	Q
2025-03-31	$6.14	Estimate	Q
2025-06-30	$7.06	Actual	Q
2025-06-30	$6.32	Estimate	Q
2025-09-30	$7.04	Projection	F
2025-12-30	$7.02	Projection	F
2026-03-30	$7.00	Projection	F
2026-06-30	$6.98	Projection	F

Net Income: Actual + Estimates

This chart tracks HCA net income: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-01-31	$1.44B	Actual	Q-Est
2024-01-31	$1.35B	Estimate	Q-Est
2024-04-30	$1.44B	Actual	Q-Est
2024-04-30	$1.35B	Estimate	Q-Est
2024-07-31	$1.44B	Actual	Q-Est
2024-07-31	$1.15B	Estimate	Q-Est
2024-09-30	$1.44B	Actual	Q-Est
2024-09-30	$1.15B	Estimate	Q-Est
2024-10-31	$1.27B	Actual	Q
2024-10-31	$1.15B	Estimate	Q
2024-12-31	$1.44B	Actual	Q-Est
2024-12-31	$1.41B	Estimate	Q-Est
2025-03-31	$1.44B	Actual	Q
2025-03-31	$1.41B	Estimate	Q
2025-06-30	$1.65B	Actual	Q
2025-06-30	$1.45B	Estimate	Q
2025-09-30	$1.62B	Projection	F
2025-12-30	$1.61B	Projection	F
2026-03-30	$1.61B	Projection	F
2026-06-30	$1.61B	Projection	F

EBITDA: Actual + Estimates

This chart tracks HCA ebitda: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-01-31	$7.10B	Actual	Q-Est
2024-01-31	$6.96B	Estimate	Q-Est
2024-04-30	$7.10B	Actual	Q-Est
2024-04-30	$6.96B	Estimate	Q-Est
2024-07-31	$7.10B	Actual	Q-Est
2024-07-31	$6.96B	Estimate	Q-Est
2024-09-30	$7.10B	Actual	Q
2024-09-30	$6.90B	Estimate	Q
2024-10-31	$7.04B	Actual	Q-Est
2024-10-31	$6.96B	Estimate	Q-Est
2024-12-31	$7.10B	Actual	Q
2024-12-31	$7.21B	Estimate	Q
2025-03-31	$7.36B	Actual	Q
2025-03-31	$7.23B	Estimate	Q
2025-06-30	$7.49B	Actual	Q
2025-06-30	$7.34B	Estimate	Q
2025-09-30	$7.59B	Projection	F
2025-12-30	$7.70B	Projection	F
2026-03-30	$7.80B	Projection	F
2026-06-30	$7.91B	Projection	F

Disclaimer: The information on this page is for educational and entertainment purposes only and does not constitute financial advice. Do your own research and consult a qualified financial advisor before making investment decisions. Data sources include Yahoo Finance and other third-party providers and may contain errors or delays.

HCA – Dividend Returns, History & Calculator

Company Info

Price Data

Dividend Data

Growth Rates

Total Returns

Fair Value

Financial Metrics

Calculate your HCA Dividend Returns

Portfolio Growth Over Time

Year-by-Year Portfolio Growth (Realistic DRIP Scenario)

HCA Dividend History

HCA 10-yr Total Return ($10,000 invested)

Total Return with and without DRIP (HCA)

HCA Dividend Reinvestment Snowball

After 20 Years

After 30 Years

Milestones on the way

How we estimate these numbers

Projected Future Returns & Dividends for HCA

Estimated Future Value + Dividends – HCA

Dividend History: Payments & Yield

Dividend Growth

Dividend Payments & Yield

HCA Dividend History

Dividend Payout Ratio

Dividend to Free Cash Flow Ratio

Share Price

Price to Earnings

Price to Sales

Revenue

Net Income

Revenue vs Net Income

Gross Profit

Operating Income

EBITDA

Operating Cash Flow

Free Cash Flow

Free Cash Flow / Share

Earnings Per Share (EPS)

Return on Equity (ROE)

Return on Assets (ROA)

Net Profit Margin

Gross Profit Margin

Cash & Debt

Shares Outstanding

Stock-Based Comp

FCF vs Stock Based Comp

FCF vs FCF / Share

Revenue: Actual + Estimates

EPS: Actual + Estimates

Net Income: Actual + Estimates

EBITDA: Actual + Estimates

Other Articles of Interest

Related stocks

Download now

Get your dividend champions spreadsheet.